Liver cirrhosis and arterial hypertension

World Journal of Gastroenterology

Volumn 12, Issue 5, 2006, Pages 678-685

  Henriksen, Jens H ^a,b   Moller, Soren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Arterial compliance; Blood pressure regulation; Central vascular filling; Chyperdynamic circulation; Kidney function; Nitric oxide; Renin angiotensin aldosterone system; Sympathetic nervous system; Vasoconstriction; Vasodilatation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE; RENIN;

ARTERIAL PRESSURE; ARTERY COMPLIANCE; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISEASE COURSE; ESSENTIAL HYPERTENSION; HEMODYNAMICS; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; REVIEW; SYSTEMIC CIRCULATION; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 33644904041     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i5.678     Document Type: Review

References (52)

1. Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ. Alcohol consumption and blood pressure. Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med 1977; 296: 1194-1200
2. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ. A prospective study of nutritional factors and hypertension among US men. Circulation 1992; 86: 1475-1484
3. Potter JF, Beevers DG. Pressor effect of alcohol in hypertension. Lancet 1984; 1: 119-122
4. Cohen L, Guillevin L, Meyrier A, Bironne P, Bletry O, Godeau P. Malignant arterial hypertension in periarteritis nodosa. Incidence, clinicobiologic parameters and prognosis based on a series of 165 cases. Arch Mal Coeur Vaiss 1986; 79: 773-778
5. Arroyo V, Gines P, Jimenez W, Rodes J: Ascites and renal dysfunction in hepatic cirrhosis: Renal dysfunction in cirrhosis. In: Oxford Textbook of Clinical Hepatology. Edited by Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodes J. Oxford University Press, 1999: 733-761.
6. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J: Peripheral artery vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 5: 1151-1157
7. Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In Portal Hypertension. Pathophysiology and Treatment. Edited by Bosch J, Groszmann RJ. Oxford: Blackwell 1994: 17-26
8. Henriksen JH, Bendtsen F, Sorensen TI, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989; 97: 1506-1513
9. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index. Am J Physiol Gastrointest Liver Physiol 2001; 280: G584-594
10. Moller S, Henriksen JH, Bendtsen F. Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 2003; 284: G970-979
11. Krousel-Wood MA, Muntner P, He J, Whelton PK. Primary prevention of essential hypertension. Med Clin North Am 2004; 88: 223-238
12. Andersen UO, Henriksen JH, Jensen G. Sources of measurement variation in blood pressure in large-scale epidemiological surveys with follow-up. Blood Pressure 2002; 11: 357-365
13. Ekataksin W, Kaneda K. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis 1999; 19: 359-382
14. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 2002; 35: 478-91
15. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339: 533-541
16. Ring-Larsen H, Henriksen JH. Pathogenesis of ascites formation and hepatorenal syndrome: humoral and hemodynamic factors. Semin Liver Dis 1986; 6: 341-52
17. Moller S, Bendtsen F, Henriksen JH. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 2001; 61: 421-499
18. Moller S, Bendtsen F, Henriksen JH. Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. Can J Gastroenterol 2001; 15: 94-106
19. Jimenez W, Arroyo V. Origins of cardiac dysfunction in cirrhosis. Gut 2003; 52: 1392-1394
20. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26: 842-847
21. Gentilini P, Romanelli RG, Laffi G, Barletta G, Del Bene R, Messeri G, La Villa G. Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. J Hepatol 1999; 30: 632-638
22. Lopez C, Jimenez W, Arroyo V, Claria J, La Villa G, Asbert M, Gaya J, Rivera F, Rodes J. Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride-induced cirrhosis. Hepatology 1991; 13: 585-589
23. Loyke HF. Reduction of hypertension after liver disease. Arch Intern Med 1962; 110: 45-49
24. Spatt SD, Rosenblatt P. The incidence of hypertension in portal cirrhosis: a study of 80 necropsied cases of portal cirrhosis. Ann Int Med 1949; 31: 479-83
25. Loyke HF, Cutarelli R. An evaluation of hypertension and liver disease in an alcoholic service. Am J Med Sci 1960; 240: 346-351
26. Schrier RW. Renin-angiotensin in preascitic cirrhosis: evidence for primary peripheral arterial vasodilation. Gastroenterology 1998; 115: 489-491
27. Moller S, Wiinberg N, Henriksen JH. Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosis. Hepatology 1995; 22: 88-5
28. Loyke HF. The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Am J Med Sci 1955; 230: 627-32
29. Veglio F, Pinna G, Melchio R, Rabbia F, Panarelli M, Schiavone D, Mulatero P, Chiandussi L. Hormonal aspects of the relation of liver cirrhosis to essential hypertension. Clin Exp Hypertens A 1992; 14: 889-903
30. Raaschou F. Blood pressure and heart weight in chronic hepatitis. Does the liver play a role in the development of essential hypertension? Nord Med 1949; 46: 1791-1795.
31. Henriksen JH, Fuglsang S, Bendtsen F, Møller S. Arterial hypertension in cirrhosis. Arterial compliance, volume distribution, and central haemodynamics. Gut 2006; 55: 380-387
32. Henriksen JH, Moller S, Schifter S, Abrahamsen J, Becker U. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems. Gut 2001; 49: 112-118
33. Brinch K, Moller S, Bendtsen F, Becker U, Henriksen JH. Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003; 39: 24-31
34. Moller S, Gulberg V, Becker U, Gerbes AL, Henriksen JH: Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin-1. Scand J Gastroenterol 2002; 37: 1064-1069
35. Henriksen JH, Gulberg V, Gerbes AL, Bendtsen F, Moller S. Increased arterial compliance in cirrhosis is related to decreased arterial C-type natriuretic peptide, but not to atrial natriuretic peptide. Scand J Gastroenterol 2003; 38: 559-564
36. Moller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9-15
37. Moller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000; 20: 51-59
38. D'Amico G. The role of vasoactive drugs in the treatment of oesophageal varices. Expert Opin Pharmacother 2004; 5: 349-360
39. Kiszka-Kanowitz M, Henriksen JH, Moller S, Bendtsen F. Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. J Hepatol 2001; 35: 605-612
40. Hadengue A, Moreau R, Gaudin C, Bacq Y, Champigneulle B, Lebrec D. Total effective vascular compliance in patients with cirrhosis: a study of the response to acute blood volume expansion. Hepatology 1992; 15: 809-815
41. Andreu V, Perello A, Moitinho E, Escorsell A, Garcia-Pagan JC, Bosch J, Rodes J. Total effective vascular compliance in patients with cirrhosis. Effects of propranolol. J Hepatol 2002; 36: 356-361
42. Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109: 1917-25
43. Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Moller S. Dyssynchronous electrical and mechanical systole in patients with cirrhosis. J Hepatol 2002; 36: 513-520
44. Henriksen JH, Gotze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 2003; 52: 1511-1517
45. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003; 362: 1819-1827
46. Moore K. Endothelin and vascular function in liver disease. Gut 2004; 53: 159-161
47. Moller S, Gulberg V, Henriksen JH, Gerbes AL. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics. J Hepatol 1995; 23: 135-144
48. Mohamed R, Forsey PR, Davies MK Neuberger JM. Effect of liver transplantation on QT interval prolongation and autonomic dysfunction in end-stage liver disease. Hepatology 1996; 23: 1128-1134
49. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-778
50. Henriksen JH, Ring-Larsen H. Renal effects of drugs used in the treatment of portal hypertension. Hepatology 1993; 18: 688-95
51. Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Gines P Moreira V, Milicua JM, Jimenez W Arroyo V. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42: 439-447
52. Schwartz DT. The relation of cirrhosis of the liver to renal hypertension. A review of 639 autopsied cases. Ann Intern Med 1967; 66: 862-869